Modi thanks Oz PM Morrison for Covaxin move, says would help post-Covid ties

“I thank my dear friend @ScottMorrisonMP for Australia’s recognition of India's COVAXIN. It is an important step forward in the post-COVID partnership between India and Australia,” Modi tweeted.
Prime Minister Narendra Modi with Australian PM Scott Morrison.
Prime Minister Narendra Modi with Australian PM Scott Morrison.
Updated on Nov 01, 2021 10:03 PM IST
Copy Link
Written by Srivatsan K C | Edited by Sohini Goswami, Hindustan Times, New Delhi

Prime Minister Narendra Modi on Monday thanked his Australian counterpart Scott Morrison after the country recognised India’s indigenously developed Covid-19 vaccine Covaxin earlier in the day.

Covaxin is the second vaccine being used in India’s inoculation programme that has been recognised in Australia following Covishield, manufactured by the Serum Institute of India.

Calling Morrison a “dear friend”, Modi hailed the recognition as an important step in the post-Covid relationship between the two countries.

“I thank my dear friend @ScottMorrisonMP for Australia’s recognition of India's COVAXIN. It is an important step forward in the post-COVID partnership between India and Australia,” Modi wrote in a tweet.

Earlier in the day, Australia's medicines and medical devices regulator Therapeutic Goods Administration (TGA) said that Covaxin, developed and manufactured by Hyderabad-based Bharat Biotech, has been recognised for vaccination as the country opened up its international borders after a gap of nearly 20 months.

Also read | Covid-19 pandemic: Australia opens door to Indians vaccinated with Covaxin

Along with Covaxin, another vaccine BBIBP-CorV, manufactured by China’s Sinopharm, was accorded recognition by the TGA.

“Today, the TGA determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be 'recognised' for the purpose of establishing a traveller's vaccination status. This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV,” it said in a statement.

The regulator said the move to recognise the vaccine would imply that the people inoculated with these shots would now be considered fully vaccinated upon entry into Australia.

“This will have significant impacts for the return of international students, and travel of skilled and unskilled workers to Australia,” it further said.

The move from Australia to recognise Covaxin came a few days after Oman had approved the vaccine and added it to its list of vaccines accepted for travel to Oman, the Indian embassy there announced on October 27.

SHARE THIS ARTICLE ON
Close Story
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, January 26, 2022